메뉴 건너뛰기




Volumn 25, Issue 5, 2012, Pages 397-402

Genetic counseling in melanoma

Author keywords

gene; genetic counseling; melanoma; mutation; predisposition

Indexed keywords

CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR 2A; MELANOCORTIN 1 RECEPTOR; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; PROTEIN P16;

EID: 84867338631     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/j.1529-8019.2012.01499.x     Document Type: Article
Times cited : (28)

References (46)
  • 1
    • 11144298761 scopus 로고    scopus 로고
    • Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi
    • Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur J Cancer 2005: 41: 28-44.
    • (2005) Eur J Cancer , vol.41 , pp. 28-44
    • Gandini, S.1    Sera, F.2    Cattaruzza, M.S.3
  • 2
    • 77949396613 scopus 로고    scopus 로고
    • Increased risk of second primary cancers after a diagnosis of melanoma
    • Bradford PT, Freedman DM, Goldstein AM, Tucker MA,. Increased risk of second primary cancers after a diagnosis of melanoma. Arch Dermatol 2010: 146: 265-272.
    • (2010) Arch Dermatol , vol.146 , pp. 265-272
    • Bradford, P.T.1    Freedman, D.M.2    Goldstein, A.M.3    Tucker, M.A.4
  • 3
    • 42649138270 scopus 로고    scopus 로고
    • Lessons from the skin - Cutaneous features of familial cancer
    • Winship IM, Dudding TE,. Lessons from the skin-cutaneous features of familial cancer. Lancet Oncol 2008: 9: 462-472.
    • (2008) Lancet Oncol , vol.9 , pp. 462-472
    • Winship, I.M.1    Dudding, T.E.2
  • 4
    • 27244435224 scopus 로고    scopus 로고
    • Population-based analysis of prognostic factors and survival in familial melanoma
    • Florell SR, Boucher KM, Garibotti G, et al. Population-based analysis of prognostic factors and survival in familial melanoma. J Clin Oncol 2005: 23: 7168-7177.
    • (2005) J Clin Oncol , vol.23 , pp. 7168-7177
    • Florell, S.R.1    Boucher, K.M.2    Garibotti, G.3
  • 5
    • 0025847504 scopus 로고
    • Hereditary cutaneous malignant melanoma: A 20-year family update
    • Anderson DE, Badzioch MD,. Hereditary cutaneous malignant melanoma: a 20-year family update. Anticancer Res 1991: 11: 433-437.
    • (1991) Anticancer Res , vol.11 , pp. 433-437
    • Anderson, D.E.1    Badzioch, M.D.2
  • 6
    • 0032887878 scopus 로고    scopus 로고
    • Counseling and DNA testing for individuals perceived to be genetically predisposed to melanoma: A consensus statement of the Melanoma Genetics Consortium
    • Kefford RF, Newton Bishop JA, Bergman W, Tucker MA,. Counseling and DNA testing for individuals perceived to be genetically predisposed to melanoma: a consensus statement of the Melanoma Genetics Consortium. J Clin Oncol 1999: 17: 3245-3251.
    • (1999) J Clin Oncol , vol.17 , pp. 3245-3251
    • Kefford, R.F.1    Newton Bishop, J.A.2    Bergman, W.3    Tucker, M.A.4
  • 7
    • 0027769876 scopus 로고
    • A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
    • Serrano M, Hannon GJ, Beach D,. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993: 366: 704-707.
    • (1993) Nature , vol.366 , pp. 704-707
    • Serrano, M.1    Hannon, G.J.2    Beach, D.3
  • 8
    • 0028931152 scopus 로고
    • Inhibition of ras-induced proliferation and cellular transformation by p16INK4
    • Serrano M, Gomez-Lahoz E, DePinho RA, Beach D, Bar-Sagi D,. Inhibition of ras-induced proliferation and cellular transformation by p16INK4. Science 1995: 267: 249-252.
    • (1995) Science , vol.267 , pp. 249-252
    • Serrano, M.1    Gomez-Lahoz, E.2    Depinho, R.A.3    Beach, D.4    Bar-Sagi, D.5
  • 9
    • 0032549704 scopus 로고    scopus 로고
    • The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53
    • Pomerantz J, Schreiber-Agus N, Liegeois NJ, et al. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 1998: 92: 713-723.
    • (1998) Cell , vol.92 , pp. 713-723
    • Pomerantz, J.1    Schreiber-Agus, N.2    Liegeois, N.J.3
  • 10
    • 0032549711 scopus 로고    scopus 로고
    • ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways
    • Zhang Y, Xiong Y, Yarbrough WG,. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 1998: 92: 725-734.
    • (1998) Cell , vol.92 , pp. 725-734
    • Zhang, Y.1    Xiong, Y.2    Yarbrough, W.G.3
  • 11
    • 36949005417 scopus 로고    scopus 로고
    • DNA damage signalling guards against activated oncogenes and tumour progression
    • Bartek J, Bartkova J, Lukas J,. DNA damage signalling guards against activated oncogenes and tumour progression. Oncogene 2007: 26: 7773-7779.
    • (2007) Oncogene , vol.26 , pp. 7773-7779
    • Bartek, J.1    Bartkova, J.2    Lukas, J.3
  • 12
    • 0030944985 scopus 로고    scopus 로고
    • Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
    • Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW,. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997: 88: 593-602.
    • (1997) Cell , vol.88 , pp. 593-602
    • Serrano, M.1    Lin, A.W.2    McCurrach, M.E.3    Beach, D.4    Lowe, S.W.5
  • 13
    • 0029664339 scopus 로고    scopus 로고
    • Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma
    • Zuo L, Weger J, Yang Q, et al. Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma. Nat Genet 1996: 12: 97-99.
    • (1996) Nat Genet , vol.12 , pp. 97-99
    • Zuo, L.1    Weger, J.2    Yang, Q.3
  • 14
    • 33750567811 scopus 로고    scopus 로고
    • High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL
    • Goldstein AM, Chan M, Harland M, et al. High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL. Cancer Res 2006: 66: 9818-9828.
    • (2006) Cancer Res , vol.66 , pp. 9818-9828
    • Goldstein, A.M.1    Chan, M.2    Harland, M.3
  • 15
    • 27144522283 scopus 로고    scopus 로고
    • Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample
    • Begg CB, Orlow I, Hummer AJ, et al. Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample. J Natl Cancer Inst 2005: 97: 1507-1515.
    • (2005) J Natl Cancer Inst , vol.97 , pp. 1507-1515
    • Begg, C.B.1    Orlow, I.2    Hummer, A.J.3
  • 16
    • 80054121869 scopus 로고    scopus 로고
    • The CDKN2A p.A148T variant is associated with cutaneous melanoma in Southern Brazil
    • Bakos RM, Besch R, Zoratto GG, et al. The CDKN2A p.A148T variant is associated with cutaneous melanoma in Southern Brazil. Exp Dermatol 2011: 20: 890-893.
    • (2011) Exp Dermatol , vol.20 , pp. 890-893
    • Bakos, R.M.1    Besch, R.2    Zoratto, G.G.3
  • 17
    • 33750626267 scopus 로고    scopus 로고
    • MC1R common variants, CDKN2A and their association with melanoma and breast cancer risk
    • Debniak T, Scott R, Masojc B, et al. MC1R common variants, CDKN2A and their association with melanoma and breast cancer risk. Int J Cancer 2006: 119: 2597-2602.
    • (2006) Int J Cancer , vol.119 , pp. 2597-2602
    • Debniak, T.1    Scott, R.2    Masojc, B.3
  • 18
    • 21144439424 scopus 로고    scopus 로고
    • Role of the CDKN2A locus in patients with multiple primary melanomas
    • Puig S, Malvehy J, Badenas C, et al. Role of the CDKN2A locus in patients with multiple primary melanomas. J Clin Oncol 2005: 23: 3043-3051.
    • (2005) J Clin Oncol , vol.23 , pp. 3043-3051
    • Puig, S.1    Malvehy, J.2    Badenas, C.3
  • 19
    • 33745190720 scopus 로고    scopus 로고
    • The A148T variant of the CDKN2A gene is not associated with melanoma risk in the French and Italian populations
    • Spica T, Portela M, Gerard B, et al. The A148T variant of the CDKN2A gene is not associated with melanoma risk in the French and Italian populations. J Invest Dermatol 2006: 126: 1657-1660.
    • (2006) J Invest Dermatol , vol.126 , pp. 1657-1660
    • Spica, T.1    Portela, M.2    Gerard, B.3
  • 20
    • 18744389747 scopus 로고    scopus 로고
    • An assessment of the CDKN2A variant Ala148Thr as a nevus/melanoma susceptibility allele
    • Bertram CG, Gaut RM, Barrett JH, et al. An assessment of the CDKN2A variant Ala148Thr as a nevus/melanoma susceptibility allele. J Invest Dermatol 2002: 119: 961-965.
    • (2002) J Invest Dermatol , vol.119 , pp. 961-965
    • Bertram, C.G.1    Gaut, R.M.2    Barrett, J.H.3
  • 21
    • 0029863304 scopus 로고    scopus 로고
    • Binding of melanotropic hormones to the melanocortin receptor MC1R on human melanocytes stimulates proliferation and melanogenesis
    • Suzuki I, Cone RD, Im S, Nordlund J, Abdel-Malek ZA,. Binding of melanotropic hormones to the melanocortin receptor MC1R on human melanocytes stimulates proliferation and melanogenesis. Endocrinology 1996: 137: 1627-1633.
    • (1996) Endocrinology , vol.137 , pp. 1627-1633
    • Suzuki, I.1    Cone, R.D.2    Im, S.3    Nordlund, J.4    Abdel-Malek, Z.A.5
  • 22
    • 0345084470 scopus 로고    scopus 로고
    • Human pigmentation phenotype: A point mutation generates nonfunctional MSH receptor
    • Frandberg PA, Doufexis M, Kapas S, Chhajlani V,. Human pigmentation phenotype: a point mutation generates nonfunctional MSH receptor. Biochem Biophys Res Commun 1998: 245: 490-492.
    • (1998) Biochem Biophys Res Commun , vol.245 , pp. 490-492
    • Frandberg, P.A.1    Doufexis, M.2    Kapas, S.3    Chhajlani, V.4
  • 24
    • 79960912284 scopus 로고    scopus 로고
    • Melanocortin 1 receptor and risk of cutaneous melanoma: A meta-analysis and estimates of population burden
    • Williams PF, Olsen CM, Hayward NK, Whiteman DC,. Melanocortin 1 receptor and risk of cutaneous melanoma: a meta-analysis and estimates of population burden. Int J Cancer 2011: 129: 1730-1740.
    • (2011) Int J Cancer , vol.129 , pp. 1730-1740
    • Williams, P.F.1    Olsen, C.M.2    Hayward, N.K.3    Whiteman, D.C.4
  • 25
    • 0034837773 scopus 로고    scopus 로고
    • MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations
    • Box NF, Duffy DL, Chen W, et al. MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations. Am J Hum Genet 2001: 69: 765-773.
    • (2001) Am J Hum Genet , vol.69 , pp. 765-773
    • Box, N.F.1    Duffy, D.L.2    Chen, W.3
  • 26
    • 77951667623 scopus 로고    scopus 로고
    • MC1R variants increase melanoma risk in families with CDKN2A mutations: A meta-analysis
    • Fargnoli MC, Gandini S, Peris K, Maisonneuve P, Raimondi S,. MC1R variants increase melanoma risk in families with CDKN2A mutations: a meta-analysis. Eur J Cancer 2010: 46: 1413-1420.
    • (2010) Eur J Cancer , vol.46 , pp. 1413-1420
    • Fargnoli, M.C.1    Gandini, S.2    Peris, K.3    Maisonneuve, P.4    Raimondi, S.5
  • 27
    • 33747882661 scopus 로고    scopus 로고
    • MITF: Master regulator of melanocyte development and melanoma oncogene
    • Levy C, Khaled M, Fisher DE,. MITF: master regulator of melanocyte development and melanoma oncogene. Trends Mol Med 2006: 12: 406-414.
    • (2006) Trends Mol Med , vol.12 , pp. 406-414
    • Levy, C.1    Khaled, M.2    Fisher, D.E.3
  • 28
    • 82555187007 scopus 로고    scopus 로고
    • A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma
    • Yokoyama S, Woods SL, Boyle GM, et al. A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma. Nature 2011: 480: 99-103.
    • (2011) Nature , vol.480 , pp. 99-103
    • Yokoyama, S.1    Woods, S.L.2    Boyle, G.M.3
  • 29
    • 82555205202 scopus 로고    scopus 로고
    • A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma
    • Bertolotto C, Lesueur F, Giuliano S, et al. A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma. Nature 2011: 480: 94-98.
    • (2011) Nature , vol.480 , pp. 94-98
    • Bertolotto, C.1    Lesueur, F.2    Giuliano, S.3
  • 30
    • 84863615237 scopus 로고    scopus 로고
    • Essential elements of genetic cancer risk assessment, counseling, and testing: Updated recommendations of the National Society of Genetic Counselors
    • Riley BD, Culver JO, Skrzynia C, et al. Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors. J Genet Couns 2011: 21: 151-161.
    • (2011) J Genet Couns , vol.21 , pp. 151-161
    • Riley, B.D.1    Culver, J.O.2    Skrzynia, C.3
  • 31
    • 0028085975 scopus 로고
    • Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus
    • Kamb A, Shattuck-Eidens D, Eeles R, et al. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat Genet 1994: 8: 23-26.
    • (1994) Nat Genet , vol.8 , pp. 23-26
    • Kamb, A.1    Shattuck-Eidens, D.2    Eeles, R.3
  • 33
    • 53349090631 scopus 로고    scopus 로고
    • CDKN2A/p16 genetic test reporting improves early detection intentions and practices in high-risk melanoma families
    • Aspinwall LG, Leaf SL, Dola ER, Kohlmann W, Leachman SA,. CDKN2A/p16 genetic test reporting improves early detection intentions and practices in high-risk melanoma families. Cancer Epidemiol Biomarkers Prev 2008: 17: 1510-1519.
    • (2008) Cancer Epidemiol Biomarkers Prev , vol.17 , pp. 1510-1519
    • Aspinwall, L.G.1    Leaf, S.L.2    Dola, E.R.3    Kohlmann, W.4    Leachman, S.A.5
  • 35
  • 36
    • 70249098475 scopus 로고    scopus 로고
    • Selection criteria for genetic assessment of patients with familial melanoma
    • Leachman SA, Carucci J, Kohlmann W, et al. Selection criteria for genetic assessment of patients with familial melanoma. J Am Acad Dermatol 2009: 61: 677-684.
    • (2009) J Am Acad Dermatol , vol.61 , pp. 677-684
    • Leachman, S.A.1    Carucci, J.2    Kohlmann, W.3
  • 38
    • 33847282821 scopus 로고    scopus 로고
    • Features associated with germline CDKN2A mutations: A GenoMEL study of melanoma-prone families from three continents
    • Goldstein AM, Chan M, Harland M, et al. Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents. J Med Genet 2007: 44: 99-106.
    • (2007) J Med Genet , vol.44 , pp. 99-106
    • Goldstein, A.M.1    Chan, M.2    Harland, M.3
  • 39
    • 0037954289 scopus 로고    scopus 로고
    • Dermatologist detection and skin self-examination are associated with thinner melanomas: Results from a survey of the Italian Multidisciplinary Group on Melanoma
    • Carli P, De Giorgi V, Palli D, et al. Dermatologist detection and skin self-examination are associated with thinner melanomas: results from a survey of the Italian Multidisciplinary Group on Melanoma. Arch Dermatol 2003: 139: 607-612.
    • (2003) Arch Dermatol , vol.139 , pp. 607-612
    • Carli, P.1    De Giorgi, V.2    Palli, D.3
  • 40
    • 82955192301 scopus 로고    scopus 로고
    • Benefits of total body photography and digital dermatoscopy ("two-step method of digital follow-up") in the early diagnosis of melanoma in patients at high risk for melanoma
    • Salerni G, Carrera C, Lovatto L, et al. Benefits of total body photography and digital dermatoscopy ("two-step method of digital follow-up") in the early diagnosis of melanoma in patients at high risk for melanoma. J Am Acad Dermatol 2012: 67: e17-27.
    • (2012) J Am Acad Dermatol , vol.67
    • Salerni, G.1    Carrera, C.2    Lovatto, L.3
  • 41
    • 58149229703 scopus 로고    scopus 로고
    • Increased risk of cancer other than melanoma in CDKN2A founder mutation (p16-Leiden)-positive melanoma families
    • de Snoo FA, Bishop DT, Bergman W, et al. Increased risk of cancer other than melanoma in CDKN2A founder mutation (p16-Leiden)-positive melanoma families. Clin Cancer Res 2008: 14: 7151-7157.
    • (2008) Clin Cancer Res , vol.14 , pp. 7151-7157
    • De Snoo, F.A.1    Bishop, D.T.2    Bergman, W.3
  • 42
    • 0037134702 scopus 로고    scopus 로고
    • Geographical variation in the penetrance of CDKN2A mutations for melanoma
    • Bishop DT, Demenais F, Goldstein AM, et al. Geographical variation in the penetrance of CDKN2A mutations for melanoma. J Natl Cancer Inst 2002: 94: 894-903.
    • (2002) J Natl Cancer Inst , vol.94 , pp. 894-903
    • Bishop, D.T.1    Demenais, F.2    Goldstein, A.M.3
  • 43
    • 65649118981 scopus 로고    scopus 로고
    • Melanoma genetics: An update on risk-associated genes
    • vii
    • Udayakumar D, Tsao H,. Melanoma genetics: an update on risk-associated genes. Hematol Oncol Clin North Am 2009: 23: 415-429, vii.
    • (2009) Hematol Oncol Clin North Am , vol.23 , pp. 415-429
    • Udayakumar, D.1    Tsao, H.2
  • 44
    • 84856641278 scopus 로고    scopus 로고
    • A unique genome-wide association analysis in extended Utah high-risk pedigrees identifies a novel melanoma risk variant on chromosome arm 10q
    • Teerlink C, Farnham J, Allen-Brady K, et al. A unique genome-wide association analysis in extended Utah high-risk pedigrees identifies a novel melanoma risk variant on chromosome arm 10q. Hum Genet 2012: 131: 77-85.
    • (2012) Hum Genet , vol.131 , pp. 77-85
    • Teerlink, C.1    Farnham, J.2    Allen-Brady, K.3
  • 45
    • 80053640638 scopus 로고    scopus 로고
    • Genome-wide linkage analysis of Swedish families to identify putative susceptibility loci for cutaneous malignant melanoma
    • Hoiom V, Tuominen R, Hansson J,. Genome-wide linkage analysis of Swedish families to identify putative susceptibility loci for cutaneous malignant melanoma. Genes Chromosomes Cancer 2011: 50: 1076-1084.
    • (2011) Genes Chromosomes Cancer , vol.50 , pp. 1076-1084
    • Hoiom, V.1    Tuominen, R.2    Hansson, J.3
  • 46
    • 79956078755 scopus 로고    scopus 로고
    • Melanomas detected in a follow-up program compared with melanomas referred to a melanoma unit
    • Salerni G, Lovatto L, Carrera C, Puig S, Malvehy J,. Melanomas detected in a follow-up program compared with melanomas referred to a melanoma unit. Arch Dermatol 2011: 147: 549-555.
    • (2011) Arch Dermatol , vol.147 , pp. 549-555
    • Salerni, G.1    Lovatto, L.2    Carrera, C.3    Puig, S.4    Malvehy, J.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.